反饋

高晟

（山西省腫瘤醫院副主任醫師）

高晟，男，醫學博士，“三晉英才^[1] ”，山西省腫瘤醫院^[2] 結直腸肛門外科副主任醫師^[3-4] 。以第一作者發表SCI論文5篇，主持山西省科技廳應用基礎研究項目1項^[5] ，擅長結直腸及肛門部腫瘤的各種根治性手術及低位直腸癌的TME保肛手術和腹腔鏡微創手術。^[3]

2010年9月至2014年3月就讀於浙江大學，攻讀博士，獲得博士學位^[6]

擅長結直腸及肛門部腫瘤的各種根治性手術及低位直腸癌的TME保肛手術和腹腔鏡微創手術。^[3-4]

以第一作者發表SCI論文5篇

MiR-489suppressestumorgrowthand invasion by targeting HDAC7 in colorectal cancer.Gao S,Liu H,Hou S,Wu L,Yang Z,Shen J,Zhou L,Zheng SS,Jiang B.Clin Transl Oncol.2018 Jun;20(6):703-712. doi: 10.1007/s12094-017-1770-7. Epub 2017 Oct 25.^[7]
Role of overexpression of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation.Sheng Gao,Bing-Yi Lin,Zhe Yang,Zhi-Yun Zheng,Zhi-Kun Liu,Li-Ming Wu,Hai-Yang Xie,Lin Zhou,Shu-Sen Zheng.2014 Jan 21eCollection2014.^[8]
Single Nucleotide Polymorphisms in the Metastasis-Associated in Colon cancer-1 Gene Predict the Recurrence of Hepatocellular Carcinoma After Transplantation.Zhiyun Zheng,Sheng Gao,Zhe Yang,Haiyang Xie,Cheng Zhang,Bingyi Lin,Liming Wu,Shusen Zheng,Lin Zhou2014 Jan 5eCollection2014^[9]
Reduced Expression of DACT2 Promotes Hepatocellular Carcinoma Progression: Involvement of Methylation-Mediated Gene Silencing.Sheng Gao,Zhe Yang,Zhi-Yun Zheng,Jia Yao,Feng Zhang,Li-Ming Wu,Hai-Yang Xie,Lin Zhou,Shu-Sen Zheng2013 Mar 7^[10]
Doxorubicin-eluting Bead Versus Conventional TACE for Unresectable Hepatocellular Carcinoma: A Meta-Analysis.Sheng Gao,Zhe Yang,Zhiyun Zheng,Jia Yao,Min Deng,Haiyang Xie,Shusen Zheng,Lin ZhouJun 2013Hepatogastroenterology,60 (124), 813-20^[11]

參考資料

展開全部收起

詞條統計